» Articles » PMID: 20729391

Mechanistic Insight into the Ability of American Ginseng to Suppress Colon Cancer Associated with Colitis

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2010 Aug 24
PMID 20729391
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently shown that American ginseng (AG) prevents and treats mouse colitis. Because both mice and humans with chronic colitis have a high colon cancer risk, we tested the hypothesis that AG can be used to prevent colitis-driven colon cancer. Using the azoxymethane (AOM)/dextran sulfate sodium (DSS) mouse model of ulcerative colitis, we show that AG can suppress colon cancer associated with colitis. To explore the molecular mechanisms of the anticancer effects of AG, we also carried out antibody array experiments on colon cells isolated at a precancerous stage. We found there were 82 protein end points that were either significantly higher (41 proteins) or significantly lower (41 proteins) in the AOM + DSS group compared with the AOM-alone (control) group. In contrast, there were only 19 protein end points that were either significantly higher (10 proteins) or significantly lower (9 proteins) in the AOM + DSS + AG group compared with the AOM-alone (control) group. Overall, these results suggest that AG keeps the colon environment in metabolic equilibrium when mice are treated with AOM + DSS and gives insight into the mechanisms by which AG protects from colon cancer associated with colitis.

Citing Articles

Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system.

Zhao L, Zhang T, Zhang K Front Immunol. 2024; 15:1353614.

PMID: 38698858 PMC: 11064651. DOI: 10.3389/fimmu.2024.1353614.


Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis.

Bullard B, McDonald S, Cardaci T, VanderVeen B, Mohammed A, Kubinak J Am J Physiol Gastrointest Liver Physiol. 2024; 326(5):G591-G606.

PMID: 38469632 PMC: 11376977. DOI: 10.1152/ajpgi.00004.2024.


Panaxynol alleviates colorectal cancer in a murine model via suppressing macrophages and inflammation.

McDonald S, Bullard B, VanderVeen B, Cardaci T, Huss A, Fan D Am J Physiol Gastrointest Liver Physiol. 2023; 325(4):G318-G333.

PMID: 37489869 PMC: 10642997. DOI: 10.1152/ajpgi.00119.2023.


Therapeutic potential and deleterious effect of glucocorticoids on azoxymethane/dextran sulfate sodium-induced colorectal cancer in mice.

Pu J, Zhou X, Liu J, Hou P, Ji M Am J Cancer Res. 2021; 11(10):4866-4883.

PMID: 34765297 PMC: 8569368.


The inhibitory effect of TU-100 on hepatic stellate cell activation in the tumor microenvironment.

Wada Y, Tokuda K, Morine Y, Okikawa S, Yamashita S, Ikemoto T Oncotarget. 2020; 11(49):4593-4604.

PMID: 33346211 PMC: 7733620. DOI: 10.18632/oncotarget.27835.


References
1.
Hofseth L, Wargovich M . Inflammation, cancer, and targets of ginseng. J Nutr. 2006; 137(1 Suppl):183S-185S. DOI: 10.1093/jn/137.1.183S. View

2.
Cui Y, Shu X, Gao Y, Cai H, Tao M, Zheng W . Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol. 2006; 163(7):645-53. DOI: 10.1093/aje/kwj087. View

3.
Guo Y, Cheng J, Jin G, Gutkind J, Hellmich M, Townsend Jr C . Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. J Biol Chem. 2002; 277(50):48755-63. DOI: 10.1074/jbc.M209016200. View

4.
Weiss C, Bohmann D . Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell Cycle. 2004; 3(2):111-3. View

5.
Lemieux E, Bergeron S, Durand V, Asselin C, Saucier C, Rivard N . Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. Int J Cancer. 2009; 125(7):1575-86. DOI: 10.1002/ijc.24485. View